Kerydin

Chemical Nametavaborole
Dosage FormSolution (topical; 5%)
Drug ClassAntifungals
SystemSkin
CompanyPharmaDerm
Approval Year2014

Indication

  • For the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.
Last updated on 6/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Kerydin (tavaborole) Prescribing Information2015Anacor Pharmaceuticals, Inc., Palo Alto, CA
Document TitleYearSource
Topical and device-based treatments for fungal infections of the toenails (review). 2020The Cochrane Database of Systematic Reviews